Go Pro

Patrick Smith Sells 10,000 Shares of Axon Enterprise (NASDAQ:AXON) Stock

Axon Enterprise logo with Aerospace background
Image from MarketBeat Media, LLC.

Key Points

  • Axon CEO Patrick Smith sold 10,000 shares on July 7 at an average price of $643.79, for proceeds of about $6.44 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan, and Smith still directly owns about 3.04 million shares.
  • Axon shares were lower in Thursday trading, falling $17.80 to $582.00. Even after the pullback, the stock has a large market cap of about $46.9 billion and remains well above its 50-day and 200-day moving averages.
  • Recent fundamentals and analyst sentiment remain supportive, with Axon reporting quarterly EPS and revenue above estimates and revenue up 33.7% year over year. Analysts currently rate the stock a consensus “Moderate Buy,” with an average target price of $722.12.
  • MarketBeat previews top five stocks to own in August.

Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) CEO Patrick Smith sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $643.79, for a total value of $6,437,900.00. Following the completion of the sale, the chief executive officer directly owned 3,040,997 shares of the company's stock, valued at $1,957,763,458.63. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise Price Performance

AXON stock traded down $17.80 on Thursday, reaching $582.00. 1,024,829 shares of the company's stock were exchanged, compared to its average volume of 1,112,986. The stock has a fifty day moving average of $451.08 and a 200-day moving average of $483.28. The firm has a market cap of $46.91 billion, a PE ratio of 233.73, a P/E/G ratio of 13.07 and a beta of 1.38. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.Axon Enterprise's quarterly revenue was up 33.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.47 earnings per share. As a group, equities analysts predict that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Institutional Trading of Axon Enterprise

Several institutional investors and hedge funds have recently modified their holdings of the business. Baillie Gifford & Co. lifted its position in Axon Enterprise by 1,198.7% during the fourth quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company's stock worth $932,869,000 after buying an additional 1,516,099 shares during the period. Edgewood Management LLC acquired a new position in shares of Axon Enterprise during the 4th quarter valued at about $846,516,000. Wellington Management Group LLP lifted its holdings in shares of Axon Enterprise by 326.9% during the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company's stock worth $874,463,000 after acquiring an additional 1,179,038 shares during the period. Norges Bank acquired a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $515,764,000. Finally, Styrax Capital LP purchased a new stake in Axon Enterprise in the first quarter valued at approximately $84,938,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research analyst reports. Barclays decreased their price objective on shares of Axon Enterprise from $682.00 to $523.00 and set an "overweight" rating on the stock in a report on Friday, May 8th. Citizens Jmp reiterated a "market outperform" rating and set a $700.00 price target on shares of Axon Enterprise in a research report on Thursday, June 25th. Weiss Ratings raised Axon Enterprise from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, May 8th. Morgan Stanley set a $600.00 price target on Axon Enterprise in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. raised their price objective on Axon Enterprise from $750.00 to $755.00 and gave the company an "overweight" rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $722.12.

Read Our Latest Report on AXON

Axon Enterprise Company Profile

(Get Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Recommended Stories

Insider Buying and Selling by Quarter for Axon Enterprise (NASDAQ:AXON)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines